Figure 2.4. Rates of reported acute hepatitis B virus infection, by age group — United States, 2004–2019
Downloads of this figure: PDFpdf icon PPTppt icon
During 2011–2019, rates of reported acute hepatitis B steadily increased among persons aged 40–49 and 50–59 years. In contrast, rates continued to remain low among children and adolescents aged 0–19 years. During 2015–2019, rates of reported acute hepatitis B have decreased by 86% among persons aged 20–29 years, likely explained, in part, because of the implementation of childhood hepatitis B vaccine recommendations in 1991. As the cohort of persons aged 20–29 years has grown older, rates of acute hepatitis B among persons aged 30–39 years began to consistently decrease beginning in 2015.
Source: Schillie S, Vellozzi C, Reingold A, et al. Prevention of hepatitis B virus infection in the United States: recommendations of the Advisory Committee on Immunization Practices. MMWR Recomm Rep 2018;67(No. RR-1):1–31.
- Figure 2.1. Number of reported acute hepatitis B virus cases and estimated infections — United States, 2012–2019
- Figure 2.2. Rates of reported acute hepatitis B virus infection, by state — United States, 2018–2019
- Figure 2.3. Rates of reported acute hepatitis B virus infection, by state or jurisdiction — United States, 2019
- Figure 2.4. Rates of reported acute hepatitis B virus infection, by age group — United States, 2004–2019
- Figure 2.5. Rates of reported acute hepatitis B virus infection, by sex — United States, 2004–2019
- Figure 2.6. Rates of reported acute hepatitis B virus infections, by race/ethnicity — United States, 2004–2019
- Figure 2.7. Availability of information regarding risk behaviors or exposures associated with reported cases of acute hepatitis B virus infection — United States, 2019
- Figure 2.8. Rates of deaths with hepatitis B virus infection listed as a cause of death among residents, by jurisdiction — United States, 2019
- Table 2.1. Number and rates of reported cases of acute hepatitis B virus infection, by state or jurisdiction — United States, 2015–2019
- Table 2.2. Number and rates of reported cases of acute hepatitis B virus infection, by demographic characteristics — United States 2015–2019
- Table 2.3. Reported risk behaviors or exposures among reported cases of acute hepatitis B virus infection — United States, 2019
- Table 2.4. Number of newly reported cases of perinatal hepatitis B virus infection, by state or jurisdiction — United States, 2019
- Table 2.5. Number and rates of newly reported cases of chronic hepatitis B virus infection, by state or jurisdiction — United States, 2019
- Table 2.6. Number and rates of newly reported cases of chronic hepatitis B virus infection, by demographic characteristics — United States, 2019
- Table 2.7. Number and rates of deaths with hepatitis B virus infection listed as a cause of death among residents, by state or jurisdiction — United States, 2015–2019
- Table 2.8. Number and rates of deaths with hepatitis B virus infections listed as a cause of death among residents, by demographic characteristics — United States, 2015–2019